Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death (Q51003983)

14 July 2018

title

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death (English)

1 reference

14 July 2018

author

Kathleen A. Cooney

24

1 reference

PubMed publication ID

27989354

26 March 2018

http://europepmc.org/abstract/MED/27989354

Alan W Partin

26

Alan W Partin

1 reference

14 July 2018

36

Jianfeng Xu

1 reference

14 July 2018

37

William B Isaacs

1 reference

14 July 2018

Patrick Craig Walsh

32

Patrick C Walsh

1 reference

14 July 2018

S Lilly Zheng

2

S Lilly Zheng

1 reference

14 July 2018

Kathleen E Wiley

15

Kathleen E Wiley

1 reference

14 July 2018

Brian T Helfand

33

Brian T Helfand

1 reference

14 July 2018

Sameep Shah

6

Sameep Shah

1 reference

14 July 2018

Kristian Novakovic

9

Kristian Novakovic

1 reference

14 July 2018

Jacqueline Petkewicz

10

Jacqueline Petkewicz

1 reference

14 July 2018

H Ballentine Carter

27

H Ballentine Carter

1 reference

14 July 2018

Michael A. Carducci

28

Michael A Carducci

1 reference

14 July 2018

Mario A Eisenberger

29

Mario A Eisenberger

1 reference

14 July 2018

Zhoujun Shen

25

Zhoujun Shen

1 reference

14 July 2018

author name string

Rong Na

1

1 reference

14 July 2018

Misop Han

3

1 reference

14 July 2018

Hongjie Yu

4

1 reference

14 July 2018

Deke Jiang

5

1 reference

14 July 2018

Charles M Ewing

7

1 reference

14 July 2018

Liti Zhang

8

1 reference

14 July 2018

Kamalakar Gulukota

11

1 reference

14 July 2018

Donald L Helseth

12

1 reference

14 July 2018

Margo Quinn

13

1 reference

14 July 2018

Elizabeth Humphries

14

1 reference

14 July 2018

Sarah D Isaacs

16

1 reference

14 July 2018

Yishuo Wu

17

1 reference

14 July 2018

Xu Liu

18

1 reference

14 July 2018

Ning Zhang

19

1 reference

14 July 2018

Chi-Hsiung Wang

20

1 reference

14 July 2018

Janardan Khandekar

21

1 reference

14 July 2018

Peter J Hulick

22

1 reference

14 July 2018

Daniel H Shevrin

23

1 reference

14 July 2018

Sam R Denmeade

30

1 reference

14 July 2018

Michael McGuire

31

1 reference

14 July 2018

Charles B Brendler

34

1 reference

14 July 2018

Qiang Ding

35

1 reference

14 July 2018

language of work or name

English

0 references

publication date

15 December 2016

1 reference

14 July 2018

published in

European Urology

1 reference

14 July 2018

volume

71

1 reference

14 July 2018

issue

5

1 reference

14 July 2018

page(s)

740-747

1 reference

14 July 2018

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Genome-wide association study of prostate cancer-specific survival

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Integrative clinical genomics of advanced prostate cancer

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Global cancer statistics, 2012

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

ClinVar: public archive of relationships among sequence variation and human phenotype

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Prostate cancer risk-associated genetic markers and their potential clinical utility

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Germline BRCA mutations denote a clinicopathologic subset of prostate cancer

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Fast and accurate short read alignment with Burrows-Wheeler transform

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Rapid progression of prostate cancer in men with a BRCA2 mutation

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Cancer risks in BRCA2 mutation carriers

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

BRCA2 mutation in Icelandic prostate cancer patients

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

BRCA mutations and risk of prostate cancer in Ashkenazi Jews

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Human Gene Mutation Database (HGMD): 2003 update

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

BRCA1 and BRCA2 have a limited role in familial prostate cancer.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Germline Mutations in the BRCA2 Gene and Susceptibility to Hereditary Prostate Cancer

30 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5535082

Subgroups of familial and aggressive prostate cancer with considerable frequencies of BRCA2 mutations

30 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/27989354

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.EURURO.2016.11.033

1 reference

14 July 2018

PMC publication ID

5535082

1 reference

14 July 2018

PubMed publication ID

27989354

1 reference

14 July 2018